We are live on ! Find out more
AMIX

Autonomix Medical

9 hedge funds and large institutions have $88.9K invested in Autonomix Medical in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

80% more funds holding

Funds holding: 59 (+4)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

11% less capital invested

Capital invested by funds: $100K → $88.9K (-$11.1K)

Holders
9
Holders Change
+4
Holders Change %
+80%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AMIX Hedge Fund Activity: Q2 2024 in Review

9 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Autonomix Medical (AMIX) for Q2 2024, worth a combined $88.9K — down 11% from $100K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AMIX positions and 1 closed out — a net gain of 4 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $40.5K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $1.98K sold.

  • 9 institutional investors held Autonomix Medical (AMIX) as of Q2 2024, up from 5 in Q1 2024.
  • Funds reported $88.9K of Autonomix Medical stock for Q2 2024, down 11% quarter-over-quarter.
  • 5 funds opened new Autonomix Medical positions in Q2 2024 and 1 closed out, a net change of +4 holders.
  • The largest Autonomix Medical buyer in Q2 2024 was Virtu Financial, an estimated $40.5K added.
  • The largest Autonomix Medical seller in Q2 2024 was Royal Bank of Canada, an estimated $1.98K sold.

Based on aggregated 13F filings for Q2 2024.